Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06397573 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ablative Stereotactic MR-Guided Adaptive Reirradiation

StatusActive, Not Recruiting
PhaseNot applicable
Started2024-06-05
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 17, 2026 (before its estimated August 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-02-13
Recruiting→Active, Not Recruiting Study Status, Sponsor/Collaborators, Contacts/Locations v4
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2027-06→2026-08
Study sitesdetails revised at 1 of 1 site
Collaborators-25 characters
Baptist Health Foundation
2024-12-05
Study Status, Eligibility v3
Eligibility criteria-90 characters
[...] on therapy treatment plan from the prior radiation therapy. Uncontrolled brain metastases, spinal cord compression, or leptomeningeal carcinomatosis. Unresolved grade 2+ toxicity (Common Terminology Criteria fo [...]
2024-06-14
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-06→confirmed 2024-06-05
Study sitesdetails revised at 1 of 1 site
2024-05-03
Study Identification, Study Status, Study Design v1
PhasePhase 1→Not applicable
Study title-17 characters
Phase 1 Trial of Ablative Stereotactic MR-Guided Adaptive Reirradiation
2024-04-30
Original filing
This research study will enroll people who have cancer in their abdomen or pelvis that was treated previously with radiation therapy. The purpose of this research study is to test the safety and possible harms of treating tumors in these regions with another round of radiation therapy, called reirradiation or "reRT." The researchers want to find out what effects (good and bad) reRT has in people with cancer in the abdomen and pelvis.
Trial Details
NCT Number NCT06397573
Lead Sponsor Baptist Health South Florida
Conditions Abdominal Cancer, Pelvic Cancer
Enrollment 10 participants
Start Date 2024-06-05
Primary Completion 2026-08 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-17